Reviews | PharmaShots

MHLW Expedites the Reviews of Gilead’s Remdesivir to Treat Patients

Tuba Khan May 4, 2020

Shots: Shots: Japan will fast-track a review of Gilead’s remdesivir to approve it for COVID-19 patients, following the US FDA’s EUA for the therapy. If approved, Remdesivir would become Japan’s […]Read More

Bausch Health Acquires Option to Purchase Allegro’s Ophthalmology Assets

AstraZeneca Reports the Results of Tagrisso (osimertinib) in P-III ADAURA Study for the Adjuvant Treatment of Patients Early-Stage EGFR-Mutated Lung Cancer

Eli Lilly Collaborates with Amgen to Boost the Global Supply of its COVID-19 Therapies

Takeda to Divest TachoSil to Corza Health for ~$416M

Samsung Bioepis to Present P-III Exploratory Analyses Results of Aybintio (bevacizumab, biosimilar) at ESMO 2020

Merck’s Brenzys (etanercept, biosimilar) Receives Health Canada Approval for Multiple Indications

Roche Reports Results of Actemra in P-III EMPACTA Study in Patients with COVID-19 Associated Pneumonia

Roche Launches Elecsys Anti-SARS-CoV-2 S Test for COVID-19 Antibodies

Lilly’s Olumiant (baricitinib) Receives CHMP’s Positive Opinion for Moderate to Severe Atopic Dermatitis

AstraZeneca and MSD’s Lynparza (Olaparib) Receives the CHMP’s Positive Opinion as 1L Maintenance Treatment for HRD-Positive Advanced Ovarian Cancer

Roche Presents New P-III Data of Tecentriq in Triple-Negative Breast Cancer at ESMO Virtual Congress 2020

AstraZeneca Reports the Results of Tagrisso (osimertinib) in P-III ADAURA Study for the Adjuvant Treatment of Patients Early-Stage EGFR-Mutated Lung Cancer

Tags : Reviews